Carregant...
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Despite the high efficacy of direct acting antivirals (DAAs) not all patients successfully clear hepatitis C virus infection, in fact, approximately 1–3% fail to reach a sustained virological response 12 weeks after end of treatment. DAA failures are characterized by advanced liver disease, specific...
Guardat en:
| Publicat a: | Clin Mol Hepatol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Association for the Study of the Liver
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6933124/ https://ncbi.nlm.nih.gov/pubmed/31042864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0022 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|